CT appearances of mucosa-associated lymphoid tissue (MALT) lymphoma. 1999

P Kessar, and A Norton, and A Z Rohatiner, and T A Lister, and R H Reznek
Department of Diagnostic Imaging, St. Bartholomew's Hospital, West Smithfield, London, UK.

Mucosa-associated lymphoid tissue (MALT) lymphoma is a low-grade lymphoma that differs from high-grade non-Hodgkin lymphoma both clinically and histologically. The CT appearances of MALT lymphoma are described. Of 40 patients referred with biopsy-proven MALT lymphoma, only seven had not had gastrectomy or chemotherapy prior to CT examination. The CT scans of these seven cases were analysed for the degree and extent of gastric wall thickening, enlargement of abdominal and extra-abdominal lymph nodes, and presence of extra-nodal disease. In all patients the stomach was distended with oral contrast medium and scans performed at narrow collimation, after intravenous administration of 20 mg hyoscine butylbromide. In six patients focal thickening of the gastric wall was 1 cm or less. One patient had thickening of over 4 cm. There was no enlargement of abdominal or extra-abdominal lymph nodes or extension to adjacent organs. Thus on CT, at presentation, MALT lymphoma results in minimal gastric wall thickening, unlike high-grade non-Hodgkin lymphoma, which typically causes bulky gastric disease, nodal enlargement and extension into adjacent organs. CT is therefore of limited value in monitoring response to treatment. With disease greater than minimal thickening, transformation to a higher grade should be considered.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D002086 Butylscopolammonium Bromide Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of the gastrointestinal tract. Hyoscinbutylbromide,Scopolaminebutylbromide,Buscapine,Buscolysin,Buscopan,Butylscopolamine,Hyoscine N-Butylbromide,N-Butylscopolammonium Bromide,Scopolan,Bromide, Butylscopolammonium,Bromide, N-Butylscopolammonium,Hyoscine N Butylbromide,N Butylscopolammonium Bromide,N-Butylbromide, Hyoscine
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

P Kessar, and A Norton, and A Z Rohatiner, and T A Lister, and R H Reznek
May 2006, Seminars in oncology nursing,
P Kessar, and A Norton, and A Z Rohatiner, and T A Lister, and R H Reznek
August 1995, Pathology international,
P Kessar, and A Norton, and A Z Rohatiner, and T A Lister, and R H Reznek
May 2010, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
P Kessar, and A Norton, and A Z Rohatiner, and T A Lister, and R H Reznek
February 2016, Revue de pneumologie clinique,
P Kessar, and A Norton, and A Z Rohatiner, and T A Lister, and R H Reznek
October 2019, QJM : monthly journal of the Association of Physicians,
P Kessar, and A Norton, and A Z Rohatiner, and T A Lister, and R H Reznek
April 2013, Clinical journal of gastroenterology,
P Kessar, and A Norton, and A Z Rohatiner, and T A Lister, and R H Reznek
October 2020, Hematological oncology,
P Kessar, and A Norton, and A Z Rohatiner, and T A Lister, and R H Reznek
August 2001, Kyobu geka. The Japanese journal of thoracic surgery,
P Kessar, and A Norton, and A Z Rohatiner, and T A Lister, and R H Reznek
December 2008, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
P Kessar, and A Norton, and A Z Rohatiner, and T A Lister, and R H Reznek
September 1996, Nihon Kyobu Shikkan Gakkai zasshi,
Copied contents to your clipboard!